|
39
|
124
|
7tuqA |
Crystal structure of brd4 bromodomain 1 in complex with monoacetylated sars-cov-2 e |
|
41
|
134
|
7tv0A |
Crystal structure of brd4 bromodomain 1 in complex with dual-acetylated sars-cov-2 e |
|
1
|
11
|
7tv0E |
Crystal structure of brd4 bromodomain 1 in complex with dual-acetylated sars-cov-2 e |
|
44
|
126
|
7q3fA |
Bromodomain-containing 4 bd1 in complex with the inhibitor crcm5484 |
|
44
|
126
|
7mr7A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-075 |
|
42
|
127
|
7mr5A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-052 |
|
42
|
126
|
7mr8A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-076 |
|
44
|
127
|
7mr6A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-082 |
|
43
|
125
|
7eigA |
Brd4-bd1 in complex with lt-730-903 |
|
45
|
124
|
7lh8A |
Crystal structure of the first bromodomain of human brd4 in complex with inhibitor jj-ii-131 |
|
46
|
125
|
7eilA |
Brd4-bd1 in complex with lt-909-110 |
|
43
|
125
|
7eikA |
Rd4-bd1 in complex with lt-872-297 |
|
43
|
127
|
8pxnA |
N-terminal bromodomain of human brd4 with (1r,1'r)-7,7'-(ethane-1,2-diylbis(oxy))bis(1,3-dimethyl-1,3-dihydro-2h-benzo[d]azepin-2-one) |
|
40
|
127
|
8pxmA |
N-terminal bromodomain of human brd4 with (1r,1'r)-7,7'-(pentane-1,5-diylbis(oxy))bis(1,3-dimethyl-1,3-dihydro-2h-benzo[d]azepin-2-one) |
|
43
|
125
|
8pxaAAA |
N-terminal bromodomain of human brd4 with (s)-5-(1-((1-(1-isopropylpiperidine-4-carbonyl)piperidin-3-yl)methyl)-1h-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1h)-one |
|
40
|
123
|
8ibqA |
Bromodomain and extra-terminal domain (bet) brd4 |
|
38
|
112
|
8idhA |
Bromodomain and extra-terminal domain (bet) brd4 |
|
45
|
123
|
8ckfA |
Crystal structure of the first bromodomain of human brd4 l94c variant in complex with racemic 3,5-dimethylisoxazol ligand |
|
44
|
127
|
8piqA |
Crystal structure of brd4-bd1 with bi894999 |
|
40
|
133
|
7yl2A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor y07004 |
|
40
|
125
|
8p9hA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb437 |
|
40
|
125
|
8p9gA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb390 |
|
39
|
125
|
8p9jA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb500 |
|
40
|
124
|
8p9iA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb462 |
|
43
|
125
|
8p9kA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb503 |
|
39
|
125
|
8p9fA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb161 |
|
41
|
125
|
8p9lA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb512 |
|
44
|
127
|
7ugfA |
First bromodomain of brd4 liganded with bms-536924 |
|
44
|
127
|
8e17B |
Brd4-d1 in complex with bet inhibitor |
|
42
|
127
|
8dyrB |
Brd4-d1 in complex with bet inhibitor |
|
45
|
127
|
8e3wB |
Brd4-d1 in complex with bet inhibitor |
|
42
|
149
|
8bdxD |
Ternary complex between vcb, brd4-bd2 and protac 48 |
|
43
|
149
|
8bdtD |
Ternary complex between vcb, brd4-bd2 and protac 51 |
|
26
|
97
|
8bdxC |
Ternary complex between vcb, brd4-bd2 and protac 48 |
|
31
|
108
|
8bdtA |
Ternary complex between vcb, brd4-bd2 and protac 51 |
|
24
|
104
|
8bdtB |
Ternary complex between vcb, brd4-bd2 and protac 51 |
|
23
|
104
|
8bdxB |
Ternary complex between vcb, brd4-bd2 and protac 48 |
|
35
|
109
|
8bdxA |
Ternary complex between vcb, brd4-bd2 and protac 48 |
|
28
|
97
|
8bdtC |
Ternary complex between vcb, brd4-bd2 and protac 51 |
|
45
|
127
|
7r5bA |
Crystal structure of brd4(1) in complex with the inhibitor mpm2 |
|
42
|
124
|
8gq0A |
Crystal structure of brd4 bromodomain 1 (bd1) in complex with stl233497 |
|
41
|
124
|
8gpzA |
Crystal structure of brd4 bromodomain 1 (bd1) in complex with c239-0012 |
|
42
|
123
|
7ymgA |
Crystal structure of brd4 bromodomain 1 (bd1) in complex with 2-({3-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}amino)-3-(1h-indol-3-yl)propan-1-ol |
|
43
|
123
|
7yq9A |
Crystal structure of brd4 bromodomain 1 (bd1) in complex with n-[2-(1h-indol-3-yl)ethyl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazin-6-amine |
|
39
|
108
|
7uskA |
Brd4-bd2 ligand free |
|
40
|
127
|
8b5bA |
Human brd4 bromdomain 1 in complex with a h4 peptide containing acetyl lysine and apmtri (h4k5ack8apmtri) |
|
39
|
109
|
7usjA |
Brd4-bd2 in complex with sf2523 |
|
43
|
126
|
8b5cA |
Human brd4 bromdomain 1 in complex with a h4 peptide containing apmtri (h4k5/8apmtri) |
|
44
|
126
|
7qdlAAA |
N-terminal bromodomain of human brd4 with i-bet567 |
|
43
|
129
|
7ze7AAA |
Brd4 in complex with fraglite21 |
